Over the past quarter, 12 of the 16 brokerages covering Celestica have elevated their recommendations to either "Buy" or "Outperform," representing a 25% increase in positive ratings compared to the prior three months. Notably, a leading Wall Street firm highlighted Celestica’s transition into higher-value hardware and software services as a key driver for its upgraded view. This elevated consensus opinion has drawn heightened institutional interest, with fund managers boosting their average stake by 18% since the beginning of the year based on the latest regulatory filings.

Celestica’s revenue mix now spans four core end markets — tech infrastructure (40%), mission-critical systems (30%), industrial automation (20%) and medical devices (10%) — reducing its exposure to any single sector. Over the past twelve months, the company has secured 15 new multi-year contracts across these domains, representing an aggregate $850 million in backlog. This level of diversification has kept quarterly revenue swings within a ±3% band, compared to ±8% in the prior fiscal year, underscoring improved resilience against sector-specific downturns.

Celestica’s shift from low-margin assembly to integrated hardware-software solutions has underpinned a 7 percentage-point increase in gross profit margin, up from 5% two years ago to 12% in the most recent quarter. Return on invested capital (ROIC) has climbed in parallel, rising from 8% in fiscal 2023 to 15% year-to-date, surpassing the 11% peer average. Management projects further margin upside as software licensing and design-services contributions grow from 18% to 30% of total revenues over the next two years, supported by the adoption of SONiC open-source software in its networking product lineup.